Abstract
An essential step in the replication cycle of all retroviruses is the dimerization of genomic RNA prior to or during encapsidation and budding. In HIV-1, a stem-loop structure in the genomic RNA called the dimerization initiation site, or DIS, has been well characterized. However, the identification of the structure(s) necessary for dimerization of HIV-2 genomic RNA has been less straightforward, as reflected by recent conflicting reports. Here, using a variety of mutant and wild-type RNA constructs and a systematic analysis of experimental conditions, we demonstrate that two dimerization sites in HIV-2 RNA are clearly discernible under different experimental conditions. A short sequence overlapping the primer binding site acts as the default dimerization site for wild-type viral RNA transcripts of several lengths provided that dimerization incubation conditions do not include a high heat step (>50 °C), and electrophoresis is carried out under mild conditions that do not deplete the RNA of magnesium. However, some RNA constructs are able to dimerize through stem-loop 1 (SL1), which is the structure homologous to the HIV-1 DIS, under certain experimental conditions. Interestingly, deletion or mutation of the default PBS dimerization site leads to efficient usage of the SL1 dimerization site. This study defines conditions under which each site may be used for dimerization and demonstrates, furthermore, the facility with which the two sites can substitute for each other. This is suggestive of a switching mechanism that may be used in the viral replication cycle.
| Original language | English |
|---|---|
| Pages (from-to) | 637-648 |
| Number of pages | 12 |
| Journal | Journal of Molecular Biology |
| Volume | 319 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2002 |
Funding
We acknowledge John Ivanovitch, Hector Valtierra, Scott Hennelly, William Bowen, and Roland Marquet for helpful discussions and critical reading of the manuscript. The pROD10 plasmids from Drs J. -M. Bechet and A. M. L. Lever were obtained from the Centralised Facility for AIDS Reagents supported by EU Programme EVA (contract QLK2-CT-1999-00609) and the UK Medical Research Council. This research is supported by the National Institutes of Health grant number AI45388 to J.S.L.
| Funder number |
|---|
| QLK2-CT-1999-00609 |
| R01AI045388 |
Keywords
- Antisense oligonucleotides
- Dimerization
- HIV-2
- Molecular recognition
- RNA structure